This lends credibility to the findings, despite the fact that the number of participants was small
Its epidemiological details are still very limited
This protection extends to the sperm DNA, reducing the incidence of DNA fragmentation
A clinical study found that NAC, given at 600 mg every 12 h for 5 days as an adjuvant therapy in septic shock, significantly improved outcomes
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
10.1016/j.cep.2015.03.023 138 NanjwadeB